Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

ENCORE_Induction Therapy in Kidney Transplantation


Date: Dec 15, 2020 02:30 PM - 03:30 PM

Fee

$0.00

CE Hours

2.00

CE Units

0.200

Registration closes on Jan 28, 2021 10:30 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

MedStar Georgetown University Hospital - Department of Pharmacy

 

 

 

   

Objectives

  • Explain the immunologic mechanisms of transplant rejection and the risk factors associated with acute rejection
  • Classify the safety, efficacy, and administration profiles of different induction agents
  • Identify optimal rabbit anti-thymocyte globulin induction dosing in kidney transplant recipients
  • Recognize current evidence for induction strategies in order to determine which kidney transplant recipients are candidates for induction therapy using thymoglobulin vs alemtuzumab vs basiliximab

Speaker(s)/Author(s)

Vidhi Gandhi, PharmD
PGY-1 Resident , MedStar Georgetown University Hospital

Activity Number

0010-9999-20-058-L01-P
Date: 12/15/20
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
   

   

Objectives

  • List the indications for a kidney transplant
  • Describe the transplant procedure
  • Identify current induction strategies used in patients with kidney transplantation
  • Recognize when the induction agents should be administered
  • State hospital specific protocols of the induction agents (thymoglobulin, alemtuzumab, basiliximab)

Speaker(s)/Author(s)

Vidhi Gandhi, PharmD
PGY-1 Resident , MedStar Georgetown University Hospital

Activity Number

0010-9999-20-058-L01-T
Date: 12/15/20
Time: 02:30 PM - 03:30 PM

CE Hours

1.00